CDEK
← All organizations

Aerie Pharmaceuticals

For profitContributed to NME

Also known as: Aerie Pharma | Aerie Pharmaceuticals | Aerie Pharmaceuticals Inc. | Aerie Pharmaceuticals, Inc. | Aerie Pharmaceuticals Ireland Ltd. | Aerie Pharmaceuticals Ireland Ltd. (Japan Branch) | AERIE PHARMS INC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Sep 1, 2007

First marketed drug

Dec 18, 2017

First NDA

Dec 18, 2017

Last known activity

Dec 6, 2023

Acquired by Novartis on Aug 23, 2022

Timeline

2000s

  1. Jul 1, 2005

    Aerie Pharmaceuticals— Founded

2010s

  1. Dec 18, 2017

    netarsudil— NDA Organization

  2. Dec 18, 2017

    netarsudil— NDA Secondary Org

  3. Mar 12, 2019

    latanoprost— Marketing Organization

  4. Dec 31, 2019

    AVX Pharma— Acquired

2020s

  1. Aug 23, 2022

    Novartis— Acquired By

Drugs by trial phase (15 distinct, 39 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 3 (4 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (50)

Details

Founded
Bedminster, NJ, US Jul 1, 2005
First NDA
Dec 18, 2017
Last known activity
Dec 6, 2023